Guangzhou, China– August , 2024 – Inc. “The EC approval of BAT2206 is anothersignificant accomplishment for Bio-Thera as...
查看详情Guangzhou, China– June 25, 2025 – Bio-TheraSolutions Inc. (688177:SH), acommercial-stage biopharmaceutical company devel...
· This new agreement marksthe fourth product in the partnership and introduces a potential cost-effectivealternative to ...
· CHMP positive opinion is based on a robust analytical,non-clinical and clinical data package comparing to the referenc...